<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01494389</url>
  </required_header>
  <id_info>
    <org_study_id>20111013-008</org_study_id>
    <nct_id>NCT01494389</nct_id>
  </id_info>
  <brief_title>The Changes of CD4+T Lymphocyte Subsets in Septic Patients</brief_title>
  <official_title>The Role of CD4+T Lymphocyte Subsets in Cell Immunity in Patients With Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to explore the value of CD4+T lymphocyte subsets in cell
      immunity in the patients with sepsis.There are immunoparalysis in septic patients,the
      important player is the change of CD4+T lymphocyte,this immunoparalysis state contribute to
      the illness progress and outcome. Comprehend the change regularity of septic patients' cell
      immunity can guide fiter and correcter treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">March 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <condition>Sepsis</condition>
  <condition>SIRS(Systemic Inflammatory Response Syndrome)</condition>
  <arm_group>
    <arm_group_label>SIRS</arm_group_label>
    <description>(1) temperature &gt; 38oC or &lt; 36oC; (2) pulse rate &gt; 90 beats/min; (3) ventilation rate &gt; 20 breaths/min or hyperventilation with a partial pressure of arterial carbon dioxide (PaCO2) &lt; 32 mmHg; (4) white blood cell (WBC) count &gt;1 2,000μL-1 or &lt; 4000 μL-1 , or &gt; 10% immature cells.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sepsis</arm_group_label>
    <description>SIRS + infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>not SIRS and have no infection</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All subjects were selected from among inpatients who were hospitalized between March 2010
        and March 2011 in the Respiratory ICU, Surgical ICU, and Emergency ICU, Chinese People's
        Liberation Army (CPLA) General Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female aged 18 years old and over;

          -  Fulfilled at least two criteria of systemic inflammatory response syndrome (a) core
             temperature higher than 38 °C or lower than 36 °C (b)respiratory rate above 20/min, or
             PCO2 below 32 mmHg (c) pulse rate above 90/min, and (d) white blood cell count greater
             than 12,000/μl or lower than &lt; 4,000/μl or less than 10% of bands.

          -  Clinically suspected infection;

        Exclusion Criteria:

          -  were under 18 years of age;

          -  were refused by the patients or his/her familiality;

          -  were suffering from acquired immunodeficiency syndrome,virlhepatitis,autoimmune
             diseases and hematology;

          -  use medicine which can affect immune system,such as Glucocorticoid and
             Immunosuppressant

          -  died within 24h after being taken into the ICU, or refused to get involved in the
             study, or gave up treatment during the period of observation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xie Li Xin, Doctor</last_name>
    <role>Study Director</role>
    <affiliation>Department Of Respiratory Diseases, Chinese PLA General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 16, 2011</study_first_submitted>
  <study_first_submitted_qc>December 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 19, 2011</study_first_posted>
  <last_update_submitted>December 16, 2011</last_update_submitted>
  <last_update_submitted_qc>December 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2011</last_update_posted>
  <keyword>CD4+T lymphocyte subsets</keyword>
  <keyword>sepsis</keyword>
  <keyword>immunoparalysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

